APA (7th ed.) Citation

Celi, C. V., Peshin, S., Dharia, A., Bashir, F., Erica, L., & Mayordomo, J. I. (2025). Exceptional Response to Pembrolizumab in Metastatic ER+/HER2− Breast Cancer With Liver Metastases: A Case Report and Literature Review. Case Reports in Oncological Medicine, 2025, 1. https://doi.org/10.1155/crom/7970572

Chicago Style (17th ed.) Citation

Celi, Claudia Villa, Supriya Peshin, Adit Dharia, Faizan Bashir, Linden Erica, and Jose I. Mayordomo. "Exceptional Response to Pembrolizumab in Metastatic ER+/HER2− Breast Cancer With Liver Metastases: A Case Report and Literature Review." Case Reports in Oncological Medicine 2025 (2025): 1. https://doi.org/10.1155/crom/7970572.

MLA (9th ed.) Citation

Celi, Claudia Villa, et al. "Exceptional Response to Pembrolizumab in Metastatic ER+/HER2− Breast Cancer With Liver Metastases: A Case Report and Literature Review." Case Reports in Oncological Medicine, vol. 2025, 2025, p. 1, https://doi.org/10.1155/crom/7970572.